The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and paediatric patients with AML or MDS
On January 21, 2025, the Food and Drug Administration approved treosulfan, an alkylating agent, with…